Table 3.
Pathology | Splenectomy | Spleen conserving | Combined |
---|---|---|---|
Adenocarcinoma | 1 (5%) | 0 (0%) | 1 (5%) |
Neuroendocrine | 4 (17%) | 4 (17%) | 8 (33%) |
IPMN | 1 (4%) | 1 (4%) | 2 (8%) |
Serous microcystic adenoma | 4 (17%) | 1 (4%) | 5 (21%) |
Mucinous cystadenoma | 2 (8%) | 1 (4%) | 3 (13%) |
Other | 5 (21%) | 0 (0%) | 5 (21%) |
Total | 17 (71%) | 7 (29%) | 24 |